The trademark UROFURAD was filed by AFLOFARM Farmacja Polska Sp. z o.o., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on April 2, 2020, and received one opposition filed on July 1, 2020 by ADAMED PHARMA S.A. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by Sokołowska-Ławniczak, Anna Maja and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 1, 2020
The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).
The Appeal with reference B R0985/2022-1 was Opposition allowed according to Article 8(1)(b) EUTMR with decision issued on December 1, 2022 by the EUIPO. The Opposition with reference B 003125457 was refused according to Article 8(1)(b) EUTMR with decision issued on April 6, 2022 by the EUIPO.